Same Name, Different Medicine
The problem is not just convenience. It is what convenience does to the formula.
A patient came to me with Reynaud’s syndrome. Her hands and feet would go cold and sometimes numb, especially in winter. From a classical Chinese medicine perspective, the pattern was straightforward: cold in the channels with underlying blood deficiency.
There is a formula for this that has been used for nearly two thousand years. It is called Dang Gui Si Ni Tang — Tangkuei Decoction for Frigid Extremities.
I prepared it for her as raw herbs, ground into powder, to be taken as a tea in a thermos. Within a week she felt better. Her hands and feet improved, as expected. But so did her menstrual pain and low back pain — symptoms she had not even come in to treat.
Then she asked a very reasonable question: was there a pill version she could take instead? She did not like the taste of raw herbs. The preparation was inconvenient. The cost of high-quality raw herbs was not trivial.
My honest answer was: there is, but it will not be the same formula.
That answer is what this essay is about.
A dietary supplement is a legal category, not a safety guarantee.
When Americans buy turmeric, ashwagandha, berberine, or any of a hundred other plant products off a shelf, they assume they are buying something fundamentally mild — softer than a drug, safer by default, close enough to food that the risk must be low.
The word supplement encourages exactly that assumption. It sounds additive. Optional. Benign. Something you layer onto your life because it might help a little.
But many of these plants do not behave like harmless extras. They affect digestion, circulation, inflammation, temperature regulation, hormones, mood, and the nervous system in measurable ways. That is precisely why people buy them.
The American supplement framework treats herbs as consumer wellness products first and medicines second — if at all. That creates two distortions at once.
First, it encourages consumers to self-prescribe potent herbs by symptom alone, with minimal guidance about constitution, pattern, dosage, formulation, interactions, or duration of use.
Second, it makes it difficult or impossible to sell many traditional formulas in their original form, because the herbs most essential to how those formulas work are often restricted, substituted, or removed altogether.
The result is a strange hybrid: herbs marketed as though they are gentle enough for mass casual use, while the tradition they came from is fragmented, weakened, and forced to practice around regulatory absences.
Herbs marketed as though they are gentle enough for mass casual use — while the tradition they came from is fragmented, weakened, and forced to practice around regulatory absences.
What’s missing from the bottle.
Traditional Dang Gui Si Ni Tang contains seven herbs. One of them is Xi Xin — Asarum, sometimes translated as wild ginger. It is not a decorative ingredient. It is the warming herb that helps the formula reach the extremities, open the channels, and dispel cold where the patient is actually suffering. Without it, the formula is altered in a meaningful way.
And yet almost no manufactured version of Dang Gui Si Ni Tang sold in the United States contains Xi Xin.
Not because every company is incompetent. Not because every practitioner-grade brand is careless. Kan Traditionals substitutes Japanese helwingia pith. Treasure of the East has rotated through several formulations. Plum Flower leaves it out. Well Being and Golden Needle both substitute. These are not bad companies. They are operating inside a regulatory and sourcing environment that makes Xi Xin extraordinarily difficult to include.
This is where people make a common mistake. They hear that an herb is banned or restricted and assume the conclusion is simple: good. If it was removed, it must have been dangerous.
Sometimes that is true. Often the story is more complicated.
Take Xi Xin.
Xi Xin belongs to the botanical family Aristolochiaceae, which includes plants associated with aristolochic acid — a compound linked to kidney toxicity and cancer. That is a serious issue. But traditional use of Xi Xin did not involve the whole plant. Classical practice uses the root and rhizome, which contain very low levels of aristolochic acid compared with the aerial parts. Traditional materia medica is specific about this.
The problem emerged when manufacturers began producing cheaper, larger-scale extracts using plant material too indiscriminately. Whole-plant extracts entered the supply chain. Cases of kidney damage appeared. Regulators, faced with a supplement market they could not reliably police ingredient by ingredient and preparation by preparation, responded by restricting products containing detectable aristolochic acid.
From a regulatory standpoint, that is understandable. If you cannot guarantee that the product on the shelf reflects the traditional preparation, you regulate for the worst-case version.
But that solution does not just remove a risky consumer product. It also sweeps up herbs that, when correctly sourced and traditionally prepared, played legitimate roles in classical formulas.
Or take Ma Huang.
For over two thousand years, Ma Huang — ephedra — was used in Chinese medicine for acute respiratory illness, cough, wheezing, and certain externally contracted cold patterns. It opens the lungs, warms the surface, promotes sweating, and is used strategically and traditionally for short durations in specific clinical situations.
That is not how America used it.
In the 1990s, supplement companies discovered that ephedrine, one of its active compounds, could be marketed as a weight-loss and energy ingredient. It was sold to people trying to get leaner, train harder, suppress appetite, and feel stimulated. It was often combined with caffeine. It was taken chronically, in higher doses, and for reasons that had very little to do with its traditional medical use.
This was not Chinese medicine. It was pharmacological strip-mining.
Predictably, adverse events accumulated: cardiovascular events, strokes, seizures, sudden deaths. By 2004, the FDA had banned ephedrine-containing supplements.
From the standpoint of the supplement market, the ban made sense. But it also meant that a classically important herb became nearly impossible to access in the United States even for trained practitioners using it in an entirely different way.
This was not Chinese medicine. It was pharmacological strip-mining.
Similar stories play out with other restricted herbs. The thread is the same. An herb enters the supplement market. Its traditional context is stripped away. It is repurposed around a mass consumer desire. Dose, indication, duration, and formulation get distorted. Problems emerge. Regulators respond to the distorted use case. And then the underlying tradition loses access too.
The herbs themselves are often not the central problem. Misuse in the supplement context is.
Same name, different formula.
Once herbs are forced into the supplement model, formulas change.
Patients almost never see this. They assume the capsule on the shelf is simply a modernized version of the classical formula. Same medicine, just more convenient.
Often it is not.
Sometimes key herbs are omitted. Sometimes substitutes are used. Sometimes proportions are changed. Sometimes the preparation is standardized around isolated markers that have more to do with manufacturing than with traditional formula architecture. Sometimes a formula survives in name but not in functional integrity.
This does not mean every manufactured formula is useless. Many are good. Some are excellent within the limits they operate under. But the public has almost no awareness of how much of herbal medicine’s precision depends on structure: exact ingredients, exact roles within the formula, exact preparation, exact matching to the patient.
Convenience flattens all of that.
Why this isn’t about “quality.”
People often think the difference between a supplement and a prescription is moral. Supplements are the commercial, lower-grade thing; prescriptions are the responsible, professional thing. That is too simple.
The real distinction is structural.
A prescription exists within a clinical relationship. Someone assesses the person. Someone decides whether the medicine fits. Someone modifies the formula if needed. Someone accounts for constitution, pattern, age, medications, timeline, pregnancy status, sensitivities, temperature tendencies, digestive strength, and the body’s likely response.
A supplement exists outside that relationship. It is designed to be sold before understanding. It must make sense on a shelf. It must appeal broadly. It must be legible to strangers. And because it must be sold to the public at scale, it must be regulated as something that can be bought without a practitioner standing there.
That commercial structure shapes the medicine long before it reaches the bottle.
The bottle on the shelf does not know you.
The modern supplement market has trained people to ask, “What herb is good for this?”
That is already the wrong question.
The better question is: what exactly is happening in this body, and what medicine, in what form, at what dose, for what period of time, is appropriate for that pattern?
That is a harder question. It does not scale as cleanly. It does not market as easily. It does not fit on a bright label with three bullets on the front. But it is much closer to how real herbal medicine works.
Real herbal medicine is a method of matching. The supplement aisle cannot do that. It cannot ask who you are. It cannot read what is happening underneath your symptoms. It cannot tell you that the herb you trust is not the herb your body needs.
The bottle on the shelf does not know you.
That is the limit of what supplements can be — and the reason herbal medicine asks for something more.
- Anna Volkova, L.Ac.